Ritter Pharmaceuticals, Inc. Skyrocketed
Tue, May 12, 2020 at 05:30 PM
Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ) rocketted at $0.72, a gain of 32.3%. On Mon 11 May 20, RTTR:NASDAQ hit a New 2-Week Intraday High of $0.65. The stock got featured on our News Catalysts scanner on Wed 29 Apr 20 at 06:12 AM in the 'MERGER' category. From Mon 27 Apr 20, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Tue 05 May 20 at $0.74 with a volume of 158M+.
About Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ)
Ritter Pharmaceuticals Inc is a specialty pharmaceutical company. it develops therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. The company focuses on development and commercialization of RP-G28.
Top 10 Gainers:
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 127.17%
- Novavax, Inc. (NVAX:NASDAQ), 62.53%
- Rand Capital Corporation (RAND:NASDAQ), 43.07%
- Super League Gaming, Inc. (SLGG:NASDAQ), 41.3%
- Babcock & Wilcox Enterprises, Inc. (BW:NYSE), 40.26%
- Gamida Cell Ltd. (GMDA:NASDAQ), 36.56%
- Naked Brand Group Limited (NAKD:NASDAQ), 34.62%
- VectoIQ Acquisition Corp. (VTIQ:NASDAQ), 32.97%
- Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ), 32.33%
- Grubhub Inc. (GRUB:NYSE), 29.07%